about
P185
Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiersComputational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic AnalysisBioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative DisordersKnowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis OntologyNeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's diseaseIs dementia research ready for big data approaches?Detection of IUPAC and IUPAC-like chemical namesUsing Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative DiseasesIn silico drug discovery approaches on grid computing infrastructures.Integration and mining of malaria molecular, functional and pharmacological data: how far are we from a chemogenomic knowledge space?Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.Identification of histone modifications in biomedical text for supporting epigenomic research.WISDOM-II: screening against multiple targets implicated in malaria using computational grid infrastructures.Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer.Big data and data repurposing - using existing data to answer new questions in vascular dementia researchCSEO - the Cigarette Smoke Exposure Ontology.HuPSON: the human physiology simulation ontology.Mining biomarker information in biomedical literature.'HypothesisFinder:' a strategy for the detection of speculative statements in scientific textNeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases.Exploring novel mechanistic insights in Alzheimer's disease by assessing reliability of protein interactions.PDON: Parkinson's disease ontology for representation and modeling of the Parkinson's disease knowledge domain.An Improved Weighted-Residue Profile Based Method of Using Protein-Ligand Interaction Information in Increasing Hits Selection from Virtual Screening: A Study on Virtual Screening of Human GPCR A2A Receptor Antagonists.SVM Based Descriptor Selection and Classification of Neurodegenerative Disease Drugs for Pharmacological Modeling.OSIRISv1.2: a named entity recognition system for sequence variants of genes in biomedical literatureA network model of genomic hormone interactions underlying dementia and its translational validation through serendipitous off-target effectGrid-added value to address malaria.From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicineChallenges and opportunities for oncology biomarker discovery.Text mining for systems biology.Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer's disease.Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features.Novel approaches to develop community-built biological network models for potential drug discovery.Detecting miRNA Mentions and Relations in Biomedical Literature.@neuLink: a service-oriented application for biomedical knowledge discovery.ADO: a disease ontology representing the domain knowledge specific to Alzheimer's disease.Development of a benchmark corpus to support the automatic extraction of drug-related adverse effects from medical case reports.PLIO: an ontology for formal description of protein-ligand interactionsAnalytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression DataMultimodal Mechanistic Signatures for Neurodegenerative Diseases (NeuroMMSig): a web server for mechanism enrichment.
P50
Q30002211-ef9e313d-48c9-2d52-a1d9-96af4e0eaabeQ47475003-d081231e-46bd-507d-18f6-b975ec9f3cb1Q52432103-bc9c828d-42bc-9da9-a5d3-b870ec5ecf9eQ52432283-d1dff3c0-40a6-2713-25bc-26ee67f2e42aQ57061383-7a5b76f2-4a7e-c194-40d0-95ecb6e0c192Q59196164-46db1b46-45b1-eb13-dfcb-742e70f28558Q59196441-d3a6abe6-46b3-3d6b-e5ff-796fa67516b6Q59196905-15f68246-47a5-4c06-0713-48094a57ddc5Q59197011-dbcb5ebc-47e1-0a0d-1358-ec56816f4725Q59197191-6030619b-4962-5927-4879-d0cffd1ab233Q59197296-a2bb3312-480f-5d4f-604d-6f088be0f29aQ59208151-617cceec-449d-93c9-37ee-261325cd3662Q59208165-ac9234d7-488f-530e-8677-16cf642b655eQ59662688-ddd12f8c-40b5-a935-7eed-08837f9e8833Q61726905-80f2e057-428a-85e2-0f7f-5a6f6e1ddaedQ63710529-5d4fc5eb-475d-190a-06cc-beef9ff28b69
P184
description
German bioinformatician
@en
wetenschapper
@nl
name
Martin Hofmann-Apitius
@ast
Martin Hofmann-Apitius
@en
Martin Hofmann-Apitius
@es
Martin Hofmann-Apitius
@nl
Martin Hofmann-Apitius
@sl
type
label
Martin Hofmann-Apitius
@ast
Martin Hofmann-Apitius
@en
Martin Hofmann-Apitius
@es
Martin Hofmann-Apitius
@nl
Martin Hofmann-Apitius
@sl
altLabel
Martin Hofmann
@en
prefLabel
Martin Hofmann-Apitius
@ast
Martin Hofmann-Apitius
@en
Martin Hofmann-Apitius
@es
Martin Hofmann-Apitius
@nl
Martin Hofmann-Apitius
@sl
P1416
P185
P1053
E-6123-2018
P106
P1153
15076954300
P1416
P184
P185
P21
P2381
P2456
P31
P3829
P496
0000-0001-9012-6720